Global particle therapy market expected to generate around USD 1439 million by 2024, at a CAGR of around 9.5% between 2018 and 2024. Increasing incidences of cancer, rising use of particle therapy in clinical trials, multiple advantages of particle therapy, the growing number of particle therapy hubs globally.
Particle Therapy Market
The report covers a forecast and an analysis of the particle therapy market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the particle therapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the particle therapy market on a global and regional level.
In order to give the users of this report a comprehensive view of the particle therapy market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new type launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the particle therapy market on a global and regional basis.
The study provides a decisive view of the particle therapy market by segmenting the market based on type, system, product, cancer type, application, and region. The segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. By type, this market includes heavy ion therapy and proton therapy. By system, the particle therapy market includes single-room and multi-room systems. By product, the particle therapy market includes cyclotrons, synchrocyclotrons, and synchrotrons. By cancer type, this market includes pediatric cancer, breast cancer, prostate cancer, head and neck cancer, lung cancer, and others. By application, this market includes research applications and treatment applications.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.
Some key players of the particle therapy market include Varian Medical Systems, Inc., Ion Beam Applications SA, Hitachi, Ltd., Mevion Medical Systems, Inc., Provision Healthcare, Sumitomo Heavy Industries, Ltd., ProTom International, Inc., Optivus Proton Therapy, Inc., Danfysik A/S, and Advanced Oncotherapy Plc, among others.
This report segments the global particle therapy market into:
Global Particle Therapy Market: By Type
Global Particle Therapy Market: By System
Global Particle Therapy Market: By Product
Global Particle Therapy Market: By Cancer Type
Global Particle Therapy Market: By Application
Global Particle Therapy Market: By Region